Efficacy Trial for the Reduction of Glabellar Lines
Public ClinicalTrials.gov record NCT02466178. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Multicenter Efficacy Trial of the Serene RF System for the Reduction of Glabellar Lines
Study identification
- NCT ID
- NCT02466178
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- Serene Medical Inc
- Industry
- Enrollment
- 78 participants
Conditions and interventions
Conditions
Interventions
- Serene RF System Device
Device
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2015
- Primary completion
- Mar 31, 2016
- Completion
- Nov 30, 2016
- Last update posted
- Mar 21, 2017
2015 – 2016
United States locations
- U.S. sites
- 5
- U.S. states
- 4
- U.S. cities
- 5
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Premier Plastic Surgery | Palo Alto | California | 94306-3811 | — |
| Premier Plastic Surgery | San Mateo | California | 94401 | — |
| Aesthetic Plastic Surgery | New York | New York | 10025 | — |
| Reviance Plastic Surgery & Aesthetics Center | Clackamas | Oregon | 97015 | — |
| Puget Sound Plastic Surgery | Kirkland | Washington | 98033 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02466178, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 21, 2017 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02466178 live on ClinicalTrials.gov.